Drug intelligence / Profile preview

chloroquine

Development stage
Approved
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous, Subcutaneous
01

Overview

Chloroquine is an antimalarial and amebicidal small molecule drug primarily used to prevent and treat malaria caused by susceptible Plasmodium species. It is also indicated for the treatment of extraintestinal amebiasis and has been used off-label for autoimmune diseases such as rheumatoid arthritis and lupus erythematosus. Chloroquine acts by inhibiting heme polymerase in malarial parasites, preventing the detoxification of heme into hemozoin within the parasite's digestive vacuole. The accumulation of toxic heme leads to parasite death. Additionally, chloroquine increases endosomal pH in host cells, which can interfere with viral entry mechanisms; however, its use for viral infections like COVID-19 is not recommended due to lack of efficacy[1][2][5][7].

Brand names
AralenAralen PhosphateAralen Hydrochloride
Other names
chloroquine phosphate
02

Targets

ACE2 (Angiotensin-converting enzyme 2)Heme

Beyond the preview

Go deeper on chloroquine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chloroquine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call